NCT00189150View on ClinicalTrials.gov

Pharmacokinetics of Mmf and Valganciclovir

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Kidney Transplant RecipientHeart Transplant Recipient
Interventions
DRUG

Mycophenolate mofetil

DRUG

Valganciclovir

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Michigan

OTHER

NCT00189150 - Pharmacokinetics of Mmf and Valganciclovir | Biotech Hunter | Biotech Hunter